Desigualdades de género en el consumo de psicofármacos en la adolescencia

Desigualdades de género en el consumo de psicofármacos en la adolescencia

Gender Inequalities in Psychotropic Drug Use in Adolescence

Title history
  • Desigualdades de género en el consumo de psicofármacos en la adolescencia — observed on 20261113-2156 UTC (YouTube)
🎙 Xabi Martínez Mendia 👥 17K 📅 November 13, 2026 ⏱ 73 min 👁 33 📄 original study 🧭 2026-11-13
Available in: English (current) Français

Keywords

antidepressantsanxiolyticsteenagersmedicalizationhealth policy

Summary

The presentation by Xabi Martínez Mendia, a doctoral researcher from the University of the Basque Country, systematically analyzes gender inequalities in adolescent psychotropic drug consumption in Spain. It begins by framing the topic within the broader context of the ‘pharmaceuticalization of distress’ and social determinants of health. Using data from the Spanish ESTUDES survey (1994-2023) and European ESPAD data, he demonstrates a sustained increase in the use of anxiolytics, hypnotics, and sedatives (AHS) among teenagers, with nearly one in five having consumed them at some point. A consistent gender gap emerges, with girls consuming almost twice as much as boys, a gap that has widened over time, particularly after 2020 for antidepressants. The analysis also reveals a socioeconomic gradient: girls with mothers of lower educational attainment, parents in unemployment, or families with high pharmaceutical co-payments show higher consumption rates. Cross-country comparisons suggest that contextual factors like GDP per capita, income inequality (Gini index), and gender inequality indicators are correlated with the magnitude of the gender gap. The speaker then shifts to explaining these trends, contrasting the hypothesis of increased actual distress with the thesis of the medicalization and pharmaceuticalization of distress. He discusses how sociocultural changes—such as the rise of psychotherapeutic language, the expansion of biomedical vocabulary, and the influence of social media on self-diagnosis—are reshaping how adolescents, especially girls, interpret and manage their emotions through pharmaceutical means.

228 words

Critical Evaluation

Value of the Information & Strength of the Argument

The primary value lies in the robust, quantitative longitudinal data spanning three decades, which clearly illustrates the gender gap and its evolution. The argumentation is structured and rigorous, moving from descriptive statistics to an exploratory analytical framework that integrates multiple axes of inequality (gender, age, socioeconomic level, parental education, family employment situation, and co-payment), effectively demonstrating intersectionality in health consumption. The inclusion of multilevel country-level analysis adds valuable depth by linking individual consumption patterns to macro-political and economic contexts (GDP, Gini coefficient, gender equality indices), thereby strengthening the hypothesis that gender gaps in psychotropic use are modulated by societal structures rather than purely medical factors. The transition to the qualitative, conceptual interpretation (pharmaceuticalization) is well-grounded in literature, citing Conrad and Williams, and presents a compelling alternative explanation to the simple narrative of rising distress, arguing that the way society addresses suffering has fundamentally altered.

Scientific Rigor, Source Quality, Title Accuracy

The presentation demonstrates high scientific rigor by explicitly naming its data sources—the ESTUDES school survey, the European ESPAD survey, and primary care clinical records—and clearly distinguishing between prescribed and non-prescribed consumption (with and without a prescription). The speaker transparently articulates the distinction between therapeutic use and self-medication. The reference to theoretical frameworks such as medicalization (Conrad) and pharmaceuticalization (Williams) provides robust academic grounding. The title is highly adequate, as the entire presentation directly addresses the question of gender inequalities in adolescent psychotropic use without digressing. The methodological limitations are implicitly acknowledged through the focus on descriptive and exploratory analysis, rather than causal inference, which aligns appropriately with the scope of a lecture presentation.

272 words

Title / Content Match

The title precisely reflects the content: the talk systematically analyzes gender differences in psychotropic drug consumption among adolescents, primarily using Spanish data.

Quality & Reliability

8/10

The presentation relies on robust national and European population-based surveys (ESTUDES, ESPAD) and primary care clinical records, showing consistent trends. The speaker is a doctoral researcher in public health, articulating methodological constraints clearly. The qualitative component (expert interviews) is briefly referenced but not detailed in this presentation, slightly limiting the full assessment of methodological rigor.

Key Moments

Contribution & Novelties

The original contribution of this presentation is its integrated, public-health-oriented analysis of adolescent psychotropic consumption, going beyond simple prevalence rates to expose how gender intersects with socioeconomic status and national policy contexts. It highlights a specific post-2020 divergence in antidepressant prescription among girls, linking the widening gap to broader societal shifts in the perception and management of distress (pharmaceuticalization). The use of co-payment data as a proxy for socioeconomic gradients is a particularly insightful methodological angle.

Pour aller plus loin :

  • Medicalization - Wikipedia — Core theoretical concept of how human conditions become defined in medical terms, as referenced by the speaker via Conrad.
  • Social determinants of health - WHO — The conceptual framework underpinning the speaker’s analysis of how social factors like income and education shape health outcomes.
  • Gender and health - WHO — Explores the WHO’s perspective on how gender norms and inequalities lead to differentiated health risks and behaviors.
  • Observatorio Español de las Drogas y las Adicciones (OEDA) - Related to the national survey ESTUDES, though official URL is subject to change, it is the institutional source of the data presented.

184 words

Radar Profile

The radar profile shows a high score on quantity of information due to the extensive datasets presented, with a slightly lower but still strong score on quality reflecting the robust methodological approach. Technical level is moderate-high, catering to a health science audience, while overall reliability remains high due to the transparent use of established official survey data.

Reliability 8/10